Immunization, HepB3 in Euro area
Euro area: Immunization, HepB3 was 90.4% in 2024. ◆ Volatile
Immunization, HepB3 in Euro area, 1985–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
Euro area recorded 90.4% for immunization, hepb3 in 2024.
The figure is up 0.2% on the previous year and up 1.8% over ten years.
Over the whole period, immunization, hepb3 in Euro area peaked at 91.0% in 2021 and was at its lowest, 0.0%, in 1985.
That places Euro area 10th out of 47 groups with data for 2024, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, HepB3 in Euro area, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1985 | 0.0% | — |
| 1986 | 0.0% | — |
| 1987 | 0.0% | — |
| 1988 | 0.0% | — |
| 1989 | 0.0% | — |
| 1990 | 0.0% | — |
| 1991 | 15.3% | — |
| 1992 | 16.2% | +6.0% |
| 1993 | 20.3% | +25.3% |
| 1994 | 24.7% | +21.6% |
| 1995 | 28.0% | +13.4% |
| 1996 | 40.4% | +44.0% |
| 1997 | 45.3% | +12.1% |
| 1998 | 56.3% | +24.4% |
| 1999 | 57.2% | +1.5% |
| 2000 | 60.3% | +5.5% |
| 2001 | 62.9% | +4.2% |
| 2002 | 64.2% | +2.1% |
| 2003 | 65.4% | +1.9% |
| 2004 | 69.1% | +5.6% |
| 2005 | 70.2% | +1.6% |
| 2006 | 71.3% | +1.5% |
| 2007 | 72.9% | +2.2% |
| 2008 | 74.3% | +2.0% |
| 2009 | 75.3% | +1.3% |
| 2010 | 79.2% | +5.1% |
| 2011 | 83.1% | +4.9% |
| 2012 | 84.0% | +1.0% |
| 2013 | 86.4% | +2.9% |
| 2014 | 88.8% | +2.8% |
| 2015 | 89.5% | +0.7% |
| 2016 | 89.9% | +0.5% |
| 2017 | 90.1% | +0.2% |
| 2018 | 89.9% | -0.2% |
| 2019 | 90.4% | +0.6% |
| 2020 | 90.7% | +0.4% |
| 2021 | 91.0% | +0.3% |
| 2022 | 90.5% | -0.6% |
| 2023 | 90.2% | -0.2% |
| 2024 | 90.4% | +0.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 0.0% | 0.0% | 0.0% | 5 |
| 1990s | 30.4% | 0.0% | 57.2% | 10 |
| 2000s | 68.6% | 60.3% | 75.3% | 10 |
| 2010s | 87.1% | 79.2% | 90.4% | 10 |
| 2020s | 90.6% | 90.2% | 91.0% | 5 |
More health data for Euro area
- Population ages 60-64, male, annual growth rate 2.04 % change on previous year (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0373 units per person (2025)
- Population ages 55-59, male, annual growth rate -0.4205 % change on previous year (2025)
- Population ages 55-59, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, male, per capita 0.0363 units per person (2025)
- Population ages 60-64, female, annual growth rate 1.75 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.0367 units per person (2025)
- Population ages 65-69, male, annual growth rate 2.8 % change on previous year (2025)
Frequently asked questions
- What is immunization, hepb3 in Euro area?
- Immunization, hepb3 in Euro area was 90.4% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in Euro area?
- The highest recorded value was 91.0% in 2021.
- What is the lowest immunization, hepb3 recorded in Euro area?
- The lowest recorded value was 0.0% in 1985.
- How does Euro area rank for immunization, hepb3?
- Euro area ranks 10th out of 47 groups with data for 2024.
- Is immunization, hepb3 rising or falling in Euro area?
- Over the last ten years it is up 1.8%. The long-run trend across the full record is volatile.
- Where does this Euro area data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 40 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.